A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Trial of BMS-986012 in Combination With Platinum and Etoposide
- Status
- COMPLETED
- Phase
- PHASE1
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC
- Status
- UNKNOWN
- Phase
- PHASE2
SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation
- Status
- TERMINATED
- Phase
- PHASE2
Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
- Status
- UNKNOWN
- Phase
- N/A
Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Abscopal Effect for Metastatic Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2